Top producers have these eight traits
November 1st 2002As I travel throughout the country, I have the opportunity to visit withsome very productive urologists, and I have identified a list of traitsthey all have in common. As reimbursements are reduced and expenses rise,physicians look for ways to maintain their income. Practices that placean emphasis on practice efficiency will be more productive and have greaterincomes.
Verapamil gel found effective in Peyronie's disease
November 1st 2002Orlando, FL-Treatment of Peyronie's disease with verapamil appears to be effective, but the drug's role is still in question and is still being investigated. In research presented at the annual AUA meeting in Orlando, FL, verapamil showed good results when applied as a topical gel, but a second study suggested that the gel does not appear to be absorbed into the tunica albuginea.
Botulinum shows promise for voiding dysfunction
November 1st 2002Pittsburgh-Botulinum toxin injections can successfully treat women with neurogenic detrusor-sphincter dyssynergia (DSD) secondary to multiple sclerosis without causing stress urinary incontinence, according to University of Pittsburgh researchers.
How long should you hold on to medical records?
October 1st 2002At some point in our lives, all physicians have to decide what to do with outdated patient records. Due to the cost of storage space, most practices are unable to maintain patient medical records indefinitely. Consequently, practices will need to develop and implement retention and destruction policies and procedures. This article will review guidelines for retaining and destroying medical records.
Urethral stricture: Urethrotomy vs. definitive repair
October 1st 2002In the treatment of urethral stricture disease, overall stricture length dictates the surgical technique to use. Thus, a well-performed retrograde urethrogram to demonstrate the distal aspect and a voiding cystourethrogram to demonstrate the proximal part of the stricture are essential to formulate a surgical plan. Cystoscopy and transperineal urethral ultrasound can further complement the investigations.
New strategies improve success of oral ED therapy
October 1st 2002Orlando, FL-Men with erectile dysfunction who fail initial treatment with sildenafil citrate (Viagra) are seeing varying degrees of improvement when therapy is supplemented with other agents, vacuum devices, or education and counseling.
Buying vs. leasing: What every urologist should know
October 1st 2002Leasing can result in lower payments and an option to buy, but also higherinterest ratesShould you buy or lease your practice's premises, a needed piece of equipment,or even those extra employees? Those are questions that face every urologist.
Renew your interest in ED or lose it to other specialists
October 1st 2002Primary care specialties now account for more than 75% of the prescriptionswritten for sildenafil citrate (Viagra), and this percentage increases almostmonthly. The number of prescriptions written by urologists has remainedstable, and as the erectile dysfunction market increases, urology's percentageof the whole continues to decline. As a specialty, urologists are very busy, and the ratio of patients tophysicians is high. Urology residents who are finishing training have atremendous number of practice opportunities, ranking second only to residentsin dermatology, according to a recent AMA survey. Just look at the numberof classified pages in this issue of Urology Times, which list some of theseopportunities, and compare it with those in an issue of 5 or 10 years ago.
De novo urgency remains a problem. Slings resolve sensory urge more sothan motor urge
October 1st 2002Orlando, FL-A sizable proportion of women with mixed stress urinaryincontinence who undergo sling surgery will benefit with concomitant resolutionof urge symptoms. However, preoperative sensory urge appears to clear moreoften than motor urge, and de novo urgency is a significant potential problemfor women being operated on for pure stress incontinence, according to resultsof a study conducted at the Cleveland Clinic.
Combination therapy improves premature ejaculation
October 1st 2002Orlando, FL-Combining sildenafil citrate (Viagra) with a popularantidepressant shows positive results for patients with premature ejaculation,according to results from two separate studies from Israel and Italy. Bothpapers were presented at the AUA annual meeting here.
Newer markers may improve on PSA's shortcomings
October 1st 2002Q What is the current state of prostate cancer markers?With prostate cancer, we are fortunate in that it has the very best markeror combination of markers for any cancer that I'm aware of, short of skincancer where visual markers are quite good. PSA's performance for predictinglocalized prostate cancer probably exceeds the performance of other cancermarkers, such as CA125 for ovarian cancer, CEA for colon cancer, and someof the genetic markers for breast cancer.
Carbon tracer promising for detecting recurrent PCa
September 1st 2002Orlando, FL-The use of radiopharmaceutical carbon-11 acetate in positron emission tomography (PET) appears to be more sensitive in picking up recurrent prostate cancer than standard imaging techniques, according to preliminary imaging studies presented at the AUA annual meeting.
Bone density scores need to be revised for men
September 1st 2002Orlando, FL-Currently established T- and Z- bone mineral density scores may require revision in order to accurately assess changes in men receiving androgen deprivation therapy, suggests an Austrian study presented at the AUA annual meeting.
Post-RP imaging modality yields disappointing results
September 1st 2002Orlando, FL-Among patients who undergo radiation treatment forprostate cancer following biochemical failure post-prostatectomy, use ofthe ProstaScint immunoscintigraphy scan appears to fail at reliably locatingdisease, researchers reported at the AUA annual meeting.
One urologist reaches his breaking point; are you next?
September 1st 2002An astounding article in this issue of Urology Times details how oneurologist quit all commercial insurance participation, then "optedout" of Medicare-and is not only surviving, but thriving. Mike Harris, MD, a well-trained, board-certified, respected urologistin Traverse City, MI, said "Enough is enough!" and did somethingabout it. He no longer exists in any private insurance carrier databaseand likewise does not appear anywhere on the Medicare radar screen.
Committee: Use high-dose RT for intermediate-risk PCa
September 1st 2002Paris-An international consensus committee has recommended that men withintermediate-risk prostate cancer be treated with high-dose 3D conformalradiotherapy-with or without hormonal therapy-rather than with combinedexternal-beam radiation and brachytherapy.